Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Proov logo — Proov offers OTC at-home testing, including the only FDA cle...

Proov

Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG.

Founded 2016 United States Erie, United States 22 employees Series A Total: $9.96M Biotechnology, Health Care +3

General Information

Company Name Proov
Founded Year 2016
Location United States Erie, United States
Employees 22
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Proov. To contact Proov, visit proovtest.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Proov compare?

A PDF of Proov and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Proov soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Proov

Proov is a biotechnology and healthcare startup based in the United States that offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG. The company, founded in 2018 by Amy Beckley, Ph.D, provides a suite of diagnostics to offer fertility insights throughout the entire menstrual cycle. Proov's offering includes easy, at-home urine tests that, when paired with the free Proov Insight app, provide a science-backed fertility coach right in the user's hand. Users can measure all menstrual hormones daily with Proov tests, then utilize the app to understand ovulation status, receive daily insights, and an Ovulation Insights score. The app then generates a personalized action plan to maximize wellness or develop a fertility strategy. The company recently secured a $9.70M Series A investment on 15 December 2021, with participation from a consortium of investors including GingerBread Capital, Lightship Capital, SteelSky Ventures, Portfolia, WCC Partners, Hambrecht Ducera Growth Ventures, and Kim Perell. Proov's focus on tracking pregnanediol glucuronide (PdG), a metabolite of progesterone, positions it as a leader in understanding hormone health. With a compelling backstory that underlines the founder's personal connection to the product, Proov stands as an innovative player in the fertility diagnostics space.

Business keywords: at-home testing, fertility diagnostics, ovulation tracking, hormone health, women's health, infertility, PdG testing, fertility app, Venture capital-backed, pregnancy support, progesterone testing, female entrepreneurship, startups, healthtech

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $9.70M 7
GingerBread Capital Lightship Capital SteelSky Ventures
GingerBread Capital, Lightship Capital +5
15 Dec 2021
Grant $256.00K 1
National Science Foundation
National Science Foundation
09 Feb 2021
Seed Round Undisclosed 2
SteelSky Ventures Texas Halo Fund
SteelSky Ventures, Texas Halo Fund
09 Sep 2020
Non Equity Assistance Undisclosed -
26 Sep 2019
Seed Round Undisclosed -
08 Aug 2018

Proov Alternatives & Competitors

View All Alternatives
Proov vs
inne
inne Germany

Measure your daily progesterone levels with the inne minilab to track your fertility and decode your...

Series A
189 employees
Biotechnology, Health Care
Proov vs
Parla
Parla United Kingdom

Adia has become Parla ✨ An expert-led community changing the conversation around fertility.

Seed
8 employees
Health Care, Health and Wellness
Proov vs
The Stork Ib2C, A Rinovum Women's Health Company
The Stork Ib2C, A Rinovum Women's Health Company United States

The Stork Ib2C, A Rinovum Women’s Health Company is a women’s health company dedicated to bringing p...

Series C
3 employees
Health Care, Medical Devices
View all alternatives

FAQ About Proov

Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful ovulation via PdG.
Proov was founded in 2016.
Proov is headquartered in Erie, United States.
Proov operates in Biotechnology, Health Care, Health and Wellness, Medical Devices and Women's Health. Its work centres on at-home testing, fertility diagnostics, ovulation tracking and hormone health.
Proov has approximately 22 employees.
Proov has completed 5 funding rounds, raising a total of $9.96M. The latest funding stage is Series A.
Top alternatives and competitors to Proov include inne, Parla, The Stork Ib2C, A Rinovum Women's Health Company, trackle GmbH, Béa Fertility. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Proov and inne are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Proov, https://bouncewatch.com/company/proov-1, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes